Attached files
file | filename |
---|---|
EX-16.1 - 024 Pharma, Inc. | ex16-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K/A
Amendment
No. 2
CURRENT
REPORT
Pursuant
to Section13 or15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest reported event): January 27, 2009
B
Green Innovations, Inc.
(Exact
name of registrant as specified in its chapter)
New Jersey | 333-120490 | 20-1862731 |
(State of organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
750 Highway 34, Matawan, NJ | 07747 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (732) 441-7700
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
r
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
r
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
r
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
r
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Section
4 - Matters Related to Accountants and Financial Statements
|
Item
4.01 Changes in Registrant's Certifying
Accountant.
|
(i)
|
On
January 27, 2010, B Green Innovations, Inc. (the “Company”) learned that
its independent accountant, Bagell, Josephs, Levine & Company, L.C.C.
(“Bagell Josephs”) would decline to stand for re-election or appointment
by the Company’s Board of Directors.
|
(ii)
|
The
principal accountant's report on the financial statements for neither of
the past two years contained an adverse opinion or a disclaimer of
opinion, nor was qualified or modified as to uncertainty, audit scope, or
accounting principles, with the exception of a going concern
qualification.
|
(iii)
|
Upon
the Board of Directors learning that Bagell Josephs would not stand for
re-election, the decision to retain the new independent accountant was
decided by the Company’s Audit Committee.
|
(iv)
|
During
the Company’s two most recent fiscal years and any subsequent interim
period preceding such resignation, declination or dismissal there were no
disagreements with the former accountant on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope
or procedure.
|
(v)
|
On
January 27, 2010, the Company engaged the firm of Rosenberg, Rich, Berman,
Baker & Company (“Rosenberg Rich”) as its new independent
accountants.
|
(vi)
|
The
Company did not consult with Rosenberg Rich regarding the application of
accounting principles to a specific transaction, either completed or
proposed, or the type of audit opinion that might be rendered on the
Company's financial statements, and no written or oral advice was provided
by Rosenberg Rich that was a factor considered by the Company in reaching
a decision as to the accounting, auditing or financial reporting
issues.
|
(vii)
|
The
Company has requested that Bagell Josephs furnish it with a letter
addressed to the Securities and Exchange Commission stating whether it
agrees with the above statements. The
requested letter is attached as Exhibit 16.1 to this Form
8-K/A.
|
Section
9 - Financial Statements and Exhibits
|
Item
9.01 Financial Statements and Exhibits.
(d)
|
Exhibits
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
B Green Innovations, Inc. | |||
Date:
February 17 ,
2010
|
By:
|
/s/ Jerome Mahoney | |
Jerome Mahoney | |||
President and Chief Executive Officer | |||
INDEX
OF EXHIBITS